These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30445763)

  • 21. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substantial Cellular Penetration of Fluorescent Imidazoquinoxalines.
    Patinote C; Cirnat N; Hadj-Kaddour K; Cuq P; Bonnet PA; Deleuze-Masquéfa C
    J Fluoresc; 2020 Dec; 30(6):1499-1512. PubMed ID: 32778995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors.
    Patinote C; Bou Karroum N; Moarbess G; Deleuze-Masquefa C; Hadj-Kaddour K; Cuq P; Diab-Assaf M; Kassab I; Bonnet PA
    Eur J Med Chem; 2017 Sep; 138():909-919. PubMed ID: 28750313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors.
    Qi J; Dong H; Huang J; Zhang S; Niu L; Zhang Y; Wang J
    Eur J Med Chem; 2018 Jan; 143():8-20. PubMed ID: 29172084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity.
    Parrino B; Carbone A; Spanò V; Montalbano A; Giallombardo D; Barraja P; Attanzio A; Tesoriere L; Sissi C; Palumbo M; Cirrincione G; Diana P
    Eur J Med Chem; 2015 Apr; 94():367-77. PubMed ID: 25778992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinoxaline-1,4-dioxide derivatives inhibitory action in melanoma and brain tumor cells.
    Silva L; Coelho P; Soares R; Prudêncio C; Vieira M
    Future Med Chem; 2019 Apr; 11(7):645-657. PubMed ID: 30964331
    [No Abstract]   [Full Text] [Related]  

  • 27. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
    Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
    Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.
    Tseng CH; Chen YR; Tzeng CC; Liu W; Chou CK; Chiu CC; Chen YL
    Eur J Med Chem; 2016 Jan; 108():258-273. PubMed ID: 26686931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agents.
    Ismail MM; Amin KM; Noaman E; Soliman DH; Ammar YA
    Eur J Med Chem; 2010 Jul; 45(7):2733-8. PubMed ID: 20236735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of dihydroquinoxalinone derivatives as BRD4 inhibitors.
    Yang Y; Zhao L; Xu B; Yang L; Zhang J; Zhang H; Zhou J
    Bioorg Chem; 2016 Oct; 68():236-44. PubMed ID: 27580186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS.
    Khier S; Moarbess G; Deleuze-Masquefa C; Solassol I; Margout D; Pinguet F; Bonnet PA; Bressolle FM
    J Sep Sci; 2009 May; 32(9):1363-73. PubMed ID: 19399864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines.
    Desplat V; Vincenzi M; Lucas R; Moreau S; Savrimoutou S; Pinaud N; Lesbordes J; Peyrilles E; Marchivie M; Routier S; Sonnet P; Rossi F; Ronga L; Guillon J
    Eur J Med Chem; 2016 May; 113():214-27. PubMed ID: 26945110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
    Lee YB; Gong YD; Kim DJ; Ahn CH; Kong JY; Kang NS
    Bioorg Med Chem; 2012 Feb; 20(3):1303-9. PubMed ID: 22226981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF 2,3-DISUBSTITUTED AND FUSED QUINOXALINES AS POTENTIAL ANTICANCER AND ANTIMICROBIAL AGENTS.
    Abbas HS; Al-Marhabi ARM; Ammar YA
    Acta Pol Pharm; 2017 Mar; 74(2):445-458. PubMed ID: 29624250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
    Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
    Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study.
    Rivera G; Andrade-Ochoa S; Romero MSO; Palos I; Monge A; Sanchez-Torres LE
    Anticancer Agents Med Chem; 2017; 17(5):682-691. PubMed ID: 27396382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Substituted anilino imidazo[1,2-a] and triazolo[4,3-a]quinoxalines. Synthesis and evaluation of in vitro biological activity.
    Corona P; Vitale G; Loriga M; Paglietti G; La Colla P; Collu G; Sanna G; Loddo R
    Eur J Med Chem; 2006 Sep; 41(9):1102-7. PubMed ID: 16828932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
    Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties.
    Palluotto F; Sosic A; Pinato O; Zoidis G; Catto M; Sissi C; Gatto B; Carotti A
    Eur J Med Chem; 2016 Nov; 123():704-717. PubMed ID: 27521587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.